Name:Ding Ma

Professor and Chairmen of Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology ;
Director of Cancer Biology Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (The Key Laboratory of Ministry of Education and Hubei Province) ;
Chairman of Professional Committee of Chinese Association for International Exchange of Health Care of Women and Children  ;
Chairman of Society of Obstetrics and Gynecology Professional Committee of Chinese Medical Association in Hubei Province .

Educational Background

Postdoctoral training, Southwestern Medical Center of Texas University, 1992-1993;
PHD, Tongji Medical University, 1990;
MS, Tongji Medical College, 1986;
BS, Tongji Medical College, 1982.


Dr. Ding Ma’s research was consistent of three closely-related key scientific issues:
1. Establishment of animal models of metastasis. A transgenic murine model of human uveal melanoma was developed in order to investigate the pathological characteristics of secondary liver metastasis and to explore the effective suppression methods. The orthopotic liver carcinoma mice models on the basis of characteristics of hepatic metastasis were also established. These models simulated to the liver carcinogenesis and metastasis, and had a very important applicative value in liver cancer associated study such as the phathophysiology of tumor invasion, metastasis and the molecular suppression strategies.
2. Screening and verifying a series of effective molecular suppressor genes that were closely associated with cancer metastasis through the systematic research in vivo and vitro based on these models establishment, which was a stable bridge and foundation from the basic research to the applied research.
3. Establishment of effective vehicle systems targeted for tumor metastasis. A series of vehicles were developed for this purpose, including adenovirus, adenovirus associated virus and tumor-selective replication adenovirus vehicles in vitro and in vivo, which combined the cancer metastasis-targeting genes to explore the possibility to block cancer metastasis. An Adv-TK gene therapy clinical trial on the liver transplantation of advanced liver cancer was performed to inhibit recurrence and metastasis.

Key Projects Involved

1. National Basic Research Program of China (973 Program)
2. National Science Foundation for Distinguished Young Scholars of China
3. National Natural Science Foundation of China
4. Foundation for Innovative Research Groups of the Ministry of Education
5. National High Technology Research and Development Program of China (863 Program)

Honors & Awards

1.Chief Scientist of 973 Program
2. Owner of the National Science Foundation for Distinguished Young Scholars of China
3. Enjoyment of the State Council special allowance
4. Outstanding contribution to the middle-aged and young experts of the Ministry of Health
5. The State Candidate of Millions of Talents Project in the New Century
6. Owner of the National Science and Technology Progress Award 
7. Owner of the Chinese Medical Science and Technology Award


More than 300 academic papers have been published in national and international academic journals (103 in SCI retrieval system) by the end of 2010.